Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial

BACKGROUND: Pharmacologic treatment options for posttraumatic stress disorder (PTSD) are limited in number and effectiveness. Medications currently in use to treat PTSD were originally approved based on their efficacy in other disorders, such as major depression. Substantial research in PTSD suggest...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlop, Boadie W, Rothbaum, Barbara O, Binder, Elisabeth B, Duncan, Erica, Harvey, Philip D, Jovanovic, Tanja, Kelley, Mary E, Kinkead, Becky, Kutner, Michael, Iosifescu, Dan V, Mathew, Sanjay J, Neylan, Thomas C, Kilts, Clinton D, Nemeroff, Charles B, Mayberg, Helen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082482/
https://www.ncbi.nlm.nih.gov/pubmed/24950747
http://dx.doi.org/10.1186/1745-6215-15-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082482/
https://www.ncbi.nlm.nih.gov/pubmed/24950747
http://dx.doi.org/10.1186/1745-6215-15-240

Ejemplares similares